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with the tripeptide-enlarged DNP hapten at each of three derivatization levels, and these preparations were compared in dose-response experiments for their capacity to produce hapten-polysaccharide-mediated selective B-cell blockade. DNP~2-SIII and small hapten dnpE~-Ficoll were also employed in order to evaluate their blockade-invoking capacity. The data obtained are presented in Fig. 1 . The normalized dose-response curves show the relative capacity of these haptenated polysaccharide agents to block the 4th-day direct PFC response to DNP22-KLH in CBA/N mice. DNP59-Ficoll was the most effective blockading agent. It produced roughly 90% suppression of 4th-day direct PFC after injection of as little as 100 pg. Due to individual mouse variation, the first statistically significant blockade with DNPsg-Ficoll occurred at the 10-ng dosage level. This still amounted to a 5,000-fold net "signal advantage" per unit of weight over the 50 /~g of DNP22-KLH which was successfully blockaded. As previously observed in normal mouse strains by Desaymard and Waldmann (20) , and Desaymard et al. (21) , reducing the derivatization level of DNP-polymers profoundly reduced their efficiency in producing hapten-specific blockade. Also, dn~5-Ficoll was particularly inefficient as a blockading agent. This implies that the tripeptide-enlarged form of the DNP hapten confers a more stable interaction with Ig receptors on target B cells, thus augmenting the blockade phenomenon. DNP52-SIII, a linear saccharide polymer, was intermediate between DNP59-Ficoll and DNP~o-Ficoll in its blockade-inducing effectiveness. This indicates that blockade is not produced exclusively by multi-branched polymers such as the haptenated Ficoll derivatives. Attempts to Blockade with Nonhaptenated Ficoll. In principle, blockade of B-cell activation by DNP-Ficoll might occur directly through its specific interaction with surface Ig receptors. Or, DNP-Ficoll might block by interaction of its polysaccharide moiety with some disparate surface component specialized to receive signals from polysaccharides or other polymeric entities. According to this latter alternative, Ig receptors would serve only to concentrate haptenated polysaccharide agents at the B-cell surface, with the carrier polysaccharide then delivering the critical signal to the defective cell. A preliminary test of this hypothesis was attempted by injecting 500/zg of AECMi2o-Ficoll into male or female hybrid mice just 1 h before immunizing them with 50 ~g of DNP~2-KLH. Our findings are presented in Table I . As often occurs, the 4th-day direct splenic PFC responses to DNP22-KLH were substantially higher in the female than in the male hybrid mice in both experiments A and B. However, AECM~2o-Ficoll did not appreciably reduce the response to DNP22-KLH in male or female hybrid mice in either experiment. A further test was carried out in parental CBAJN mice using AECM~-Ficoll. Here the preliminary injection of this pelysaccharide carrier was given 4 h before primary immunization with DNP22-KLH, and the AECMs3-Ficoll dosage was increased to 2 mg (Table II) . Although this latter dose represents a 200,000-fold higher dosage of Ficoll than the 10 ng of DNPs~-Ficoll which provided significant blockade in Fig. i, no 
* Five CBA/N female mice per group; all mice in all groups were immunized with 50 pg of DNP22-KLH, i.p. $ First and second blocking agents given 10 min apart at ~2 h before immunization with DNP22-KLH. § Differs significantly from group I; P < 0.005. II The tripeptide-enlarged free hapten, N-(2,4-dinitrophenyl)-B-alanylglycylglycine Boc-hydrazide. ¶ Does not differ significantly from group I; P > 0. 10. ineffective by itself in producing hapten-specific blockade. Free hapten and free Ficoll carrier administered concomitantly were also ineffective, even when each was employed at a 100-fold higher concentration (group V) than its effective concentration when covalently combined (group II). In addition, 500 ~g of 
Temporal Requirements for Production of Specific Hapten-Ficoll-Mediated
Blockade. CBA/N mice were given 10 ~tg of DNP59-Ficoll at various intervals before immunization with DNP22-KLH and their direct splenic PFC responses were measured 4 days after immunization. The findings are depicted in Fig. 2 which discloses that the blockade phenomenon is obtained at least as efficiently with DNP59-Ficoll delivered at -24 h as it is when the blockading agent is given at the time of immunization. DNP59-Ficoll delivered at successively longer time intervals before immunization was progressively less effective in causing the blockade. When delivered 14 days before DNP22-KLH immunization, 10 ~g of DNP59-Ficoll reduced the mean 4th-day PFC response to 18% of that in the control mice. Sufficient individual variation occurred in this group, however, so that the mean PFC reduction was not statistically significant. Thus, it appears that some mice have largely escaped from blockade ai~r 14 days, but in others, the blockade remains relatively intact.
In another set of experiments, DNP59-Ficoll was given at intervals ranging up to 48 h after immunization with 50 ~g of DNP22-KLH. The findings provided in Table IV , show that significant blockade was obtained in both CBAJN and F1 male hybrid mice when DNP59-Ficoll was given up to 4 h after DNP~2-KLH immunization. The findings also suggest that hybrid male mice may be susceptible to blockade for a longer time after immunization than their CBAJN parents. 
The Effects of Prior Immune Status on the Capacity to Respond to DNP59-FicoU.
Although CBA/N mice and the hybrid male progeny of CBA/N females are unable to respond directly to DNP~-Ficoll, the existence of a specific haptenFicoll-mediated blockade implies a significant interaction of their B cells with this polysaccharide agent. Conceivably, B cells from DNP22-KLH-primed CBA/ N mice might recognize the DNP~9-Ficoll signal as immunogenic. Thus, priming with DNP22-KLH might induce in defective mice some DNP-reactive memory B cells which could then undergo activation on subsequent encounter with DNP59-Ficoll.
Male and female hybrid mice were immunized with DNP22-KLH and after 15 days, were challenged either with DNP22-KLH or with DNPsg-Ficoll. The results of splenic PFC assays performed 4 days later are presented in Table V . Memory to DNP22-KLH had been generated in beth the male and female hybrid mice since their indirect PFC already exceeded their direct PFC on the 4th day post challenge (groups IV and VIII). In hybrid female mice, challenge with DNP59-Ficoll caused both the direct and indirect PFC responses to be lower in DNP22-KLH-primed than in unprimed animals (compare group VII with group V). It is important to note that for hybrid females, the immunogenicity of DNP59-Ficoll is not neutralized by any circulating antibodies produced in response to prior immunization with DNP22-KLH (compare groups VI and VII).
In male hybrid mice, the 4th-day direct and indirect PFC responses after challenge with DNP59-Ficoll were both modestly elevated; but, the response levels did not differ significantly from the residual activity observed in control mice immunized 19 days earlier with DNP22-KLH (compare group HI with group II). It is conceivable that some defective F1 male memory cells may be ultimately triggered by subsequent contact with DNP59-Ficoll; however, the effect as currently observed falls far short of functional restoration.
Attempts to Impose Hapten-Specific Blockade on Memory Cell Populations in CBA/N Mice. Although generation of hapten-specific memory cell populations in defective mice conferred little if any capacity to respond directly to DNP59-Ficoll, it was important to ascertain whether memory B cells, like precursor B cells, were susceptible to haptenated-Ficoll blockade. CBAJN mice were immunized with DNP22-KLH, and 10 days later they were challenged with the same antigen either with or without coexistent DNP59-Ficoll blockade. Our findings are recorded in Table VI . Again, indirect PFC outnumber direct PFC at 4 days after secondary challenge with DNP22-KLH (compare group HI with group II). DNP59-Ficoll could not produce significant reductions in either the direct or indirect PFC responses of these memory cell-bearing defective CBA/N mice. Thus, the generation of memory cell populations allows escape from blockade in these defective mice even though it does not confer any capacity for direct responsiveness to DNPs~-Ficoll. Whether or not circulating antibody elicited by prior encounter with DNP22-KLH could neutralize the blockading capacity of DNP59-Ficoll is uncertain. Such antibody does not neutralize the immunogenicity of DNP59-Ficoll in normal hybrid female mice (Table V) .
The Effect of DNP59-Ficoll-Mediated Blockade on the Development of B-Cell Memory to DNP22-KLH. Although DNP59-Ficoll virtually abrogates the 4th-day secretory B-cell response to DNP22-KLH, it was not clear whether DNP59- reduced with time after exposure to DNP59-Ficoll (Fig. 2) , it was important to recheck these findings at a time when memory cell populations might reasonably be expected to first appear. The same experiment was repeated, but the DNP22-KLH challenge was given on day 8 rather than on day 30. Our findings are presented in Table VIII . Prior blockade with DNP59-Ficoll did not prevent the full development of memory B-cell populations in response to the concomitant administration of DNP22-KLH (groups III vs. IV). Efforts to produce secondary blockade at day 8 again failed to significantly reduce the indirect PFC response; the reduction of the direct PFC response, however, was marginally significant (groups IV vs. V). The overall effect stands in marked contrast to the effectiveness of DNP59-Ficoll in blockading the primary 4th-day secretory PFC response to DNP22-KLH. Apparently, blockade of 4th-day secretory B-cell responses is of little predictive value for blockade of memory B-cell responsiveness in CBAJN mice.
Discussion
The B Cell as the Probable Target of Hapten-Polysaccharide-Mediated Blockade. Our current findings focus attention on B cells as the probable direct targets of the X-linked hapten-specific blockade phenomenon. Polysaccharides carrying the tripeptide-enlarged DNP hapten were profoundly more efficient in producing blockade than was another polysaccharide bearing the traditional small form of the dnp hapten (Fig. 1 ). This implies a critical role for Ig receptors in the blockade phenomenon, as does the fact that increased haptenic density on the polysaccharide agents results in increased blocking efficiency. Multiple Ig receptors probably must be cross-linked by haptenated polymer for blockade to ensue, since unjoined free hapten and free Ficoll carrier (each provided at 100-fold their usual conjugated dosage) were unable to produce blockade. In addition, DNP59-Ficoll given at the usual 10 pg dosage level could not be functionally displaced by prior injection of a 50-fold excess of nonhaptenated AECM12o-Ficoll (Table III) .
It has been proposed (6) that the CBAJN B-cell defect in responsiveness to thymic-independent antigens may be expressed at any of three levels: (a) a failure to bind thymic-independent antigens on B-cell surfaces, (b) a failure to recognize thymic-independent antigens once they are bound on B-cell surfaces or (c) the absence of a unique B-cell subpopulation with the capacity to respond to thymic-independent antigens. Our present findings indicate that CBAJN mice do have B cells which can recognize polysaccharide antigens; the recognition event, however, leads uniquely to B-cell blockade rather than to B-cell activation. Thus, it is still possible that CBAJN mice may be intrinsically unable to recognize haptenated polysaccharides in any way that would lead to secretory activation of their defective B cells. In general, our present findings favor the view that in unprimed CBA/N mice, a unique B-cell subpopulation is functionally missing.
Possible Mechanisms of B-Cell Blockade. The presence of a B-cell defect in CBA/N mice is well established (3, 4) . If indeed macrophages and T cells are not directly involved in the intrinsic defect, then hypotheses which emphasize Bcell characteristics may be constructed in an attempt to explain the functional defect. In principle, hapten-specific blockade of relevant B-cell clones could occur through critical interactions between Ig receptors on such B cells and (a) monovalent haptens, (b) the Ficoll carrier molecule 2 (here a disparate or unique secondary receptor specific for polysaccharide would be required to initiate the blocking signal3), (c) both of the above, i.e., separate recognition of both the hapten and the carrier moieties by the same cell, or (d) multivalent hapten. In this latter case, no receptor specialized for recognition of the polymeric carrier would be required, but a geometrically acceptable presentation of the haptenic epitopes to surface Ig receptors would suffice to effect blockade. In principle, this mechanism would allow blockade by haptenated polymers other than haptenated polysaccharides, as long as the critical requirements of epitope presentation geometry were met (22) . Our current data appear to be supportive of either mechanism (c) or (d). If mechanism (d) is operative, then the requirements for critical epitope presentation can be about equally well met by either linear or multi-branched haptenated polysaccharide blocking agents (Fig. 1) .
The joint signal provided by hapten-conjugated carrier could be either passive or active in nature. It is conceivable that the multiple site interaction which occurs between Ig receptors and multivalent haptenated Ficoll prevents dissociation of hapten from these Ig receptors, and thereby assures saturative preemption of most available receptors. Such a blockade mechanism would be passive in nature and would not necessarily require metabolic changes in the cell. At present, no adequate explanation can be offered for why cell capping and consequent shedding of antigen-antibody complexes would not provide for an early escape of B cells from such hapten-specific blockade.
The marked effectiveness of X-linked hapten-polysaccharide-mediated blockade, even at extremely low dosage levels (Fig. 1) , seems consistent with an active role for haptenated polysaccharide blocking agents. In this instance, the joint signal provided by haptenated polysaccharide would produce distinct metabolic changes in the B cell. These changes would make the B cell refractory to subsequent thymic-dependent signals for secretory activation. Presumably refractoriness to secretory activation would not preclude memory cell activation.
A related concept has recently been proposed to account for B-cell activation in normal mice (22) . According to this concept, an activation signal for normal B cells can be accomplished by the formation of"immunons" at B-cell surfaces. An "immunon" is formed when ~12-16 Ig receptors are linked together by antigen in a spatially continuous cluster which can contribute to an activation signal. The number of geometrically stable "immunons" which must be formed on any given B-cell surface in order to cause its activation is unknown. Since many thymic-independent antigens are intrinsically nonmitogenic (5), and are thus presumably incapable of delivering an ordinary mitogenic second signal, the "immunon" concept is especially attractive.
The currently advanced alternative (which might apply only to defective CBA/N mice) requires only that a similar geometrically stable arrangement of cell surface Ig might be generated by haptenated polysaccharide agents. These blocking agents would then actively lead to a refractory B-cell state. For convenience, such a critical arrangement of cell surface Ig receptors might be termed a "toleron." Conceivably, the generally increased density of Ig surface receptors on the B cells of CBA/N mice (6) might predispose to "toleron" development.
Refractoriness of B Memory Cells to Hapten-Polysaccharide.Mediated Blockade. Although CBAJN mice appear to be delinquent in the development of mature IgM to IgD-type cell surface receptor relationships (7, 8, 23) , prior immunization with a thymic-dependent antigen generates specific B memory cell populations. This maturational change is accompanied, no doubt, by marked changes in the representation and density of surface Ig receptors on the specifically affected B-cell clones (11, 12) . Thus, some responding B cells may escape their usual prolonged infancy. These memory cells are apparently no longer susceptible to haptenated polysaccharide-induced blockade, but they have still not acquired any appreciable capacity for direct responsiveness to haptenated polysaccharide antigens (Table V) . Why changes in Ig receptor density could lead to escape from susceptibility to blockade without recovery of some capacity for direct responses to polysaccharide antigens cannot be readily explained. One possibility is that circulating antibody generated at the time of memory cell induction with DNP~2-KLH could effectively intercept and neutralize the blockading capacity of DNP59,Ficoll. In this case, the memory cells would not actually be subjected to blockade, and their failure to respond to challenge with DNPs~-Ficoll would simply represent maintenance of their innate unresponsiveness to that antigen.
The early observations of Baker et al. (24) extended by Schrader and Nossal (13) have demonstrated that even "end-stage" secretory B cells are susceptible to external stimuli imposed by surface-bound antigens. This phenomenon has been termed effector cell blockade, and Schrader has recently shown (14) that it is accomplished by multipoint interactions with Ig receptors. He has also shown that specific enzymatic interruption of such Ig linkages results in the reversibility of the delivered signal. The work of Klaus has emphasized that B precursor cells of normal mice are also susceptible (at quite high dosages) to specific hapten-polysaccharide-imposed blockade (10) (11) (12) . Thus, it seems reasonable to assume that B precursors as well as B secretory cells might well be susceptible to Ig receptor-mediated cell surface stimuli.
The fact that those conditions optimal for secretory B-cell blockade failed almost completely to cause B memory cell blockade indicates that some signal from the thymic-dependent DNP~2-KLH is reaching at least some B cells. It is difficult to imagine that such near total escape from blockade could occur if blockade is routinely accomplished by a metabolically active but reversible switching event on B precursor cells. This argument seems especially cogent since memory cell formation was virtually complete when tested at 8 days postblockade (Table VIII) , but secretory cell detection was still minimal when primary DNP~2-KLH stimulation was given as late as 14 days after DNP59-Ficoll injection (Fig. 2) . At present it is not possible to tell whether the precursors for secretory and for memory B cells represent two distinct subpopulations in CBA/N mice, or whether there is actually only one targeted precursor population. If a single precursor population is involved, then the signal requirements for immunogen-triggered differentiation into memory cells must be minimal as compared to those required for maturation into immediate secretory function. In any case, memory cell formation in these B-cell defective mice must clearly escape blockade more readily than secretory cell activation.
The Significance of Hapten-Polysaccharide-Mediated Selective Immune Blockade. The present study emphasizes the importance of Ig receptors for induction of specific hapten-polysaccharide-mediated B-cell blockade in defective CBA/N mice. It has disclosed the refractoriness of B memory cells to blockade, and the inevitability of memory cell development despite the presence of profound secretory cell blockade. It also raises many questions among which are: (a) is blockade strictly and exclusively a B-cell function? (b) does blockade represent merely a passive saturation of surface Ig receptors on B cells? (c) is participation of a second category of non-Ig receptors necessary for transmission of the blockade signal? (d) is the signal for blockade on any given B cell reversible? (e) can memory cell formation proceed in the presence of a complete and sustained secretory B-cell blockade? and finally, (D to what extent do the cellular and molecular events which lead to the X-linked blockade of CBA/N B cells resemble the events which cause hapten-specific blockade of normal B cells? Clear answers to any of the first five questions will be distinctly useful, but a definitive answer to the final question could ultimately be of major importance in efforts to control detrimental B-cell responses. Summary CBA/N mice, a mutant CBA subline, harbor an X-linked B-cell defect which prevents them from mounting immune responses to certain thymic-independent antigens such as pneumococcal polysaccharides and haptenated-Ficoll derivatives. These mice and the hybrid male progeny of CBAJN females are also exquisitely sensitive to a hapten-specific blockade of their otherwise adequate immune responses to thymic-dependent antigens such as N-2,4-dinitrophenylated-hemocyanin (DNP-KLH). As little as 10 ng of a DNP-Ficoll conjugate given 2 h before immunization with a 5,000-fold greater dosage of DNP-KLH, virtually abolishes the 4th-day direct plaque-forming cell (PFC) response specific for DNP. Responding hybrid (CBA/N × C3H/HeN) female mice are resistant to such blockade even at DNP-Ficoll dosages increased by three orders of magnitude. The DNP hapten and Ficoll must be chemically joined for this blocking effect to occur, and increasing the hapten derivatization of FicoU increases its blockade-invoking capacity. Significant blockade can be produced by administering DNP-Ficoll as early as 4 days before or as late as 4 h after immunization with DNP-KLH. All currently available data point to the defective B cell as the target of this hapten-polysaccharide-mediated blockade. Mice bearing B memory cells, however, are refractory to such blockade. In addition, DNP-Ficoll injections which cause virtually total blockade of 4th-day primary direct PFC responses to DNP-KLH have little or no effect on the development of DNP-reactive B-cell memory measured at either 8 or 30 days. These findings suggest very different blockade susceptibilities for B cells or their precursors at various stages of differentiative development. Our findings also lead to the formulation of testable hypotheses regarding the mechanism of this selective B-cell blockade phenomenon.
